Try our Advanced Search for more refined results
Nalox-1 Pharmaceuticals, LLC v. Opiant Pharmaceuticals, Inc.
Case Number:
Case Type:
IPR
Status:
Final Written Decision
Petitioner:
Nalox-1 Pharmaceuticals, LLC
Patent Owner:
Opiant Pharmaceuticals, Inc.
Tech Center:
1600
-
August 24, 2020
PTAB Upholds Entirety Of 3 Narcan Patents
The Patent Trial and Appeal Board has refused to invalidate three different patents covering Adapt Pharma Ltd.'s opioid overdose treatment Narcan, two of which had a different fate in district court.
-
August 28, 2019
PTAB Grants Narcan IP Review, Rejects Redundant Petitions
The Patent Trial and Appeal Board has agreed to review a patent covering the opioid overdose treatment Narcan, but turned away two other challenges to the same patent as part of a larger effort to nip redundant reviews.